Dr. Dusenbery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Harvard St Se
University Of Minnesota Physicians
Minneapolis, MN 55455Phone+1 612-273-6700
Education & Training
- University of MinnesotaResidency, Radiation Oncology, 1987 - 1990
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1985 - 1987
- Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1982 - 1985
- Wayne State University School of MedicineClass of 1982
Certifications & Licensure
- MN State Medical License 1985 - 2025
- MI State Medical License 1983 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2022
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Start of enrollment: 2014 Sep 02
- Post-contracture Release Radiation for Dupuytren's Disease Start of enrollment: 2019 May 31
Publications & Presentations
PubMed
- 54 citationsWolman disease successfully treated by bone marrow transplantationWilliam Krivit, Charles Peters, Kathryn E. Dusenbery, Yoav Ben-Yoseph, N. K. C. Ramsay
Bone Marrow Transplantation. 2000-09-01 - 33 citationsInfluence of Total Body Irradiation Dose Rate on Idiopathic Pneumonia Syndrome in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.Robert W. Gao, Daniel J. Weisdorf, Todd E. DeFor, E. Ehler, Kathryn E. Dusenbery
International Journal of Radiation Oncology, Biology, Physics. 2019-01-01 - 4 citationsPhase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.Najla El Jurdi, Alex Hoover, Daniel O'Leary, Qing Cao, Ashish Gupta
Transplantation and Cellular Therapy. 2023-09-01
Press Mentions
- University of Minnesota First in U.S. To Offer New Targeted Therapy for Recurrent Brain TumorsFebruary 14th, 2019
- Decision-Making Input Linked to More Satisfied Cancer PatientsApril 23rd, 2014
- Seymour H. Levitt, MD, 1928-2017February 9th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: